Literature DB >> 17882621

Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury.

Barbara Stanley1, Beth Brodsky, Joshua D Nelson, Rebecca Dulit.   

Abstract

The purpose of this study is to evaluate the effectiveness of a shorter course of Dialectical Behavior Therapy (DBT) in enhancing treatment retention and reducing: urges to engage in non-suicidal self injury (NSSI), NSSI, suicide ideation, and subjective distress in borderline personality disorder (BPD). Twenty patients with BPD received a six-month course of Dialectical Behavior Therapy (DBT-B). DBT-B was delivered in the standard manner except for the shortened duration from one-year minimum to six months. All variables were measured at baseline, and at six months. Data were analyzed using paired t-tests. Treatment retention rate was 95%. Significant reductions were found in NSSI urges, NSSI, suicide ideation, subjective distress, depression, and hopelessness between baseline and six months. These results support the use of DBT-B in a six-month format when NSSI and suicidal behavior and ideation are the targeted behaviors. Target behaviors were reduced significantly and retention was extremely high in comparison to other interventions for this population. A large scale randomized controlled trial investigating its efficacy is warranted to determine if the results can be replicated and if improvement can be sustained.

Entities:  

Mesh:

Year:  2007        PMID: 17882621     DOI: 10.1080/13811110701542069

Source DB:  PubMed          Journal:  Arch Suicide Res        ISSN: 1381-1118


  22 in total

Review 1.  Suicidal risk and management in borderline personality disorder.

Authors:  Marianne Goodman; Tracey Roiff; Allison H Oakes; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 2.  Effectiveness of different psychotherapy approaches in the treatment of borderline personality disorder.

Authors:  Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

3.  Treatment of borderline personality disorder in youth.

Authors:  Robert S Biskin
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

4.  Predictors of suicide-related hospitalization among U.S. veterans receiving treatment for comorbid depression and substance dependence: who is the riskiest of the risky?

Authors:  Jennifer Mrnak-Meyer; Susan R Tate; Jessica C Tripp; Matthew J Worley; Archana Jajodia; John R McQuaid
Journal:  Suicide Life Threat Behav       Date:  2011-08-04

5.  Development of an Intervention for Nonsuicidal Self-Injury in Young Adults: An Open Pilot Trial.

Authors:  Margaret S Andover; Heather T Schatten; Blair W Morris; Ivan W Miller
Journal:  Cogn Behav Pract       Date:  2015-11

Review 6.  Treating nonsuicidal self-injury: a systematic review of psychological and pharmacological interventions.

Authors:  Brianna J Turner; Sara B Austin; Alexander L Chapman
Journal:  Can J Psychiatry       Date:  2014-11       Impact factor: 4.356

Review 7.  Management of borderline personality disorder.

Authors:  Robert S Biskin; Joel Paris
Journal:  CMAJ       Date:  2012-10-01       Impact factor: 8.262

8.  Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study.

Authors:  Federico Amianto; Andrea Ferrero; Andrea Pierò; Elisabetta Cairo; Giuseppe Rocca; Barbara Simonelli; Simona Fassina; Giovanni Abbate-Daga; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2011-11-21       Impact factor: 3.630

Review 9.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

10.  Borderline personality disorder and the misdiagnosis of bipolar disorder.

Authors:  Camilo J Ruggero; Mark Zimmerman; Iwona Chelminski; Diane Young
Journal:  J Psychiatr Res       Date:  2009-11-03       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.